澳股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

IMUGENE LTD

0.250

-0.020-7.41%

08月01日 16:12 澳洲时间延时15分钟

成交量：378.10万

成交额：97.54万

市值：7,212.43万

市盈率：-0.42

高：0.277

开：0.270

低：0.245

收：0.270

分时

5日

日K

周K

月K

季K

年K

1分

5分

10分

15分

30分

1小时

2小时

更多

分时

5日

日K

周K

月K

季K

年K

1分

5分

10分

15分

30分

1小时

2小时

数据加载中...

总览公司新闻公告

免疫基因向澳洲证交所提交证券报价申请

IMUGENE LTD将举办Azer-cel新数据线上说明会

华尔街洞察

BUZZ-澳大利亚Imugene因折价配售股价暴跌

华尔街洞察

免疫基因宣布获机构认购2250万美元配股每股定价0.33澳元

华尔街洞察

Imugene宣布以每股0.33澳元价格完成2250万美元配售同步启动1500万澳元购股计划

华尔街洞察

IMUGENE LTD证券发行提案

华尔街洞察

IMU-IMU.AX宣布拟议发行证券计划

华尔街洞察

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/IMU.AU/news?region=SGP"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMU.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMU.AU\",,,,,undefined,":{"symbol":"IMU.AU","market":"AU","secType":"STK","nameCN":"IMUGENE LTD","latestPrice":0.25,"timestamp":1754028720000,"preClose":0.27,"halted":0,"volume":3781003,"delay":0,"nameEN":"IMUGENE LTD","floatShares":185861959,"shares":288497336,"eps":-0.597999,"marketStatus":"休市中","change":-0.02,"latestTime":"08-01 16:12:00 AEST","open":0.27,"high":0.277,"low":0.245,"amount":975385,"amplitude":0.118519,"askPrice":0.255,"askSize":16500,"bidPrice":0.25,"bidSize":121872,"shortable":3,"etf":0,"ttmEps":-0.597999,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1754265600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.27,"openAndCloseTimeList":[[1754006400000,1754028000000]],"volumeRatio":1.0656554869602035,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMU.AU\",,,,,undefined,":{"symbol":"IMU.AU","floatShares":185861959,"roa":"-42.92%","roe":"-100.19%","lyrEps":-0.717911,"volumeRatio":1.0656554869602035,"shares":288497336,"dividePrice":0,"high":0.277,"amplitude":0.118519,"preClose":0.27,"low":0.245,"week52Low":0.245,"pbRate":"1.14","psRate":"-39.21","week52High":2.754,"institutionHeld":0,"latestPrice":0.25,"committee":0.761512,"eps":-0.597999,"divideRate":0,"volume":3781003,"delay":0,"ttmEps":-0.597999,"open":0.27,"prevYearClose":1.258,"prevWeekClose":0.27,"prevMonthClose":0.27,"prevQuarterClose":0.442,"fiveDayClose":0.27,"twentyDayClose":0.476,"sixtyDayClose":0.782},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMU.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1155449886","title":"免疫基因向澳洲证交所提交证券报价申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1155449886","media":"美股洞察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155449886?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 14:42","pubTimestamp":1752648148,"startTime":"0","endTime":"0","summary":"澳大利亚生物技术企业Imugene Limited于今日正式向澳大利亚证券交易所递交证券报价申请文件。此举标志着该公司资本运作进入新阶段，市场关注其后续流动性变化可能带来的投资机会。根据披露流程，该申请需经交易所合规部门审核。若获批准，IMU普通股将获得持续报价资格，有助于提升二级市场交易活跃度。IMU股价近三个月累计上涨27%，跑赢ASX全普通指数15个百分点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMU.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"1101643828","title":"IMUGENE LTD将举办Azer-cel新数据线上说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=1101643828","media":"华尔街洞察","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101643828?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 11:11","pubTimestamp":1752635482,"startTime":"0","endTime":"0","summary":"生物技术企业IMUGENE LTD宣布即将召开专题线上会议，重点展示其核心候选疗法Azer-cel的最新临床进展。此次会议将披露该细胞治疗产品在血液肿瘤领域的关键数据集，涵盖治疗响应率、安全特性及作用机制等核心维度。作为靶向CD19的CAR-T疗法，Azer-cel采用创新基因编辑技术以增强抗肿瘤活性。IMUGENE LTD首席执行官强调：\"这些数据标志着我们在实体瘤治疗领域迈出重要一步，为推进后期临床试验奠定了坚实基础。此次数据披露或将影响市场对该企业估值预期的重新评估。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","IMU.AU","BK7067"],"gpt_icon":0},{"id":"1178224095","title":"BUZZ-澳大利亚Imugene因折价配售股价暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=1178224095","media":"华尔街洞察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178224095?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 10:35","pubTimestamp":1752633338,"startTime":"0","endTime":"0","summary":"Imugene股票今日盘中重挫，一度暴跌18.8%至0.345澳元，创下7月2日以来新低；最终收跌11.8%，报0.375澳元。每股0.33澳元的发行价较7月11日收盘价折价22.4%，突显了市场对折价融资的负面反应。公司还计划通过股票购买计划额外融资1500万澳元，发行价相同。Azer-cel是一种同种异体CAR T细胞疗法，专为治疗复发或难治性弥漫性大B细胞淋巴瘤设计。今日交易量激增至170万股，是30天平均水平的2.9倍。年内迄今，该股已暴跌70.2%，计入今日跌幅。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMU.AU","BK7508","BK7067"],"gpt_icon":0},{"id":"1121226572","title":"免疫基因宣布获机构认购2250万美元配股 每股定价0.33澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1121226572","media":"华尔街洞察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121226572?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 09:35","pubTimestamp":1752629732,"startTime":"0","endTime":"0","summary":"澳大利亚生物技术公司免疫基因今日宣布完成两项重要融资安排。根据公告，该公司已获得机构投资者承诺认购价值2250万美元的配售股份，每股定价为0.33澳元。与此同时，公司还启动了股票购买计划，拟以相同每股价格向现有股东募资最高1500万澳元。此次配售定价较该公司最近收盘价折让约12%，融资总额相当于当前市值的近两成。澳交所数据显示，该公司股价过去三个月累计上涨逾40%，反映出市场对其技术平台前景的积极预期。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","IMU.AU","BK7067"],"gpt_icon":0},{"id":"1144997549","title":"Imugene宣布以每股0.33澳元价格完成2250万美元配售 同步启动1500万澳元购股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1144997549","media":"华尔街洞察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144997549?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 09:26","pubTimestamp":1752629179,"startTime":"0","endTime":"0","summary":"澳大利亚生物制药企业Imugene今日披露重大融资进展。该公司已成功获得总额2250万美元的机构配售确定承诺，配售价格定为每股0.33澳元。此次配售获得市场积极响应，彰显投资者对公司发展前景的信心。在完成配售的同时，Imugene宣布启动上限为1500万澳元的购股计划。作为专注于癌症免疫治疗领域的创新企业，Imugene管线包含多款处于临床阶段的候选药物，此次资金到位将加速其关键项目的试验进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMU.AU","BK7508","BK7067"],"gpt_icon":0},{"id":"1182081065","title":"IMUGENE LTD证券发行提案","url":"https://stock-news.laohu8.com/highlight/detail?id=1182081065","media":"华尔街洞察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182081065?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 09:05","pubTimestamp":1752627944,"startTime":"0","endTime":"0","summary":"IMUGENE LTD近日宣布一项证券发行计划，旨在通过发行新证券筹集资金。该提案涉及公司战略发展，目标是为未来增长项目注入资本，增强市场竞争力。公司强调，此举将优化财务结构，并为投资者提供更多机会。发行细节尚待监管机构批准，预计将根据市场条件推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","IMU.AU"],"gpt_icon":0},{"id":"1198493033","title":"IMU-IMU.AX宣布拟议发行证券计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1198493033","media":"华尔街洞察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198493033?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 09:02","pubTimestamp":1752627730,"startTime":"0","endTime":"0","summary":"IMU-IMU.AX公司近日披露了一项证券发行提案。该计划旨在推动企业融资活动，具体条款尚待进一步公告。投资者可关注后续披露以获取详情。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMU.AU","BK7067","BK7508"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMU.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-07-02","symbol":"IMU.AU","type":"split","dateTimestamp":1751378400000,"forFactor":34,"toFactor":1,"ratio":34}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMU.AU\",market:\"AU\",,,undefined,":[]}}

如果下载按钮点击无跳转，请点击右上角菜单选择 “在浏览器打开”

立即咨询
下载APP
扫码下载APP